Here’s What Leerink Partners Thinks About BrightSpring Health (BTSG)

​BrightSpring Health Services, Inc. (NASDAQ:BTSG) is one of the Hot Growth Stocks to Invest in Right Now. On March 18, Leerink Partners reiterated an Outperform rating on BrightSpring Health Services, Inc. (NASDAQ:BTSG) with a price target of $49.

​The rating comes after the company held its investor day, where it highlighted strength and consistency. Management introduced a new long-term organic EBITDA growth target of 15% to 20% through 2028, signaling robust expansion plans. The firm noted that the company’s Specialty segment stands to benefit from LDD wins, pipeline innovation, and generics uptake. Moreover, the Provider segment leverages scale, operational reliability, and margin improvements for sustained performance.

​The firm sees acceleration in Infusion and Home & Community segments, along with a strong merger and acquisition pipeline and AI-driven efficiency gains. Leerink named the company as one of its top picks for 2026 due to favorable earnings revisions and growth tailwinds.

​BrightSpring Health Services, Inc. (NASDAQ:BTSG) provides a platform for delivering complementary health care and pharmaceutical solutions. It operates in two segments: Pharmacy Solutions and Provider Services.

While we acknowledge the risk and potential of BTSG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BTSG and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 High-Flying Penny Stocks to Buy and 10 Cheap Stocks to Buy for High Returns in 2026. 

Disclosure: None. Follow Insider Monkey on Google News.